Shan Dong Dong-E E-Jiao Co Ltd - Asset Resilience Ratio
Shan Dong Dong-E E-Jiao Co Ltd (000423) has an Asset Resilience Ratio of 20.44% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2024)
This chart shows how Shan Dong Dong-E E-Jiao Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Shan Dong Dong-E E-Jiao Co Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Shan Dong Dong-E E-Jiao Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shan Dong Dong-E E-Jiao Co Ltd market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥2.61 Billion | 20.44% |
| Total Liquid Assets | CN¥2.61 Billion | 20.44% |
Asset Resilience Insights
- Good Liquidity Position: Shan Dong Dong-E E-Jiao Co Ltd maintains a healthy 20.44% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Shan Dong Dong-E E-Jiao Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shan Dong Dong-E E-Jiao Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.62% |
|
Suven Pharmaceuticals Limited
NSE:SUVENPHAR |
Drug Manufacturers - Specialty & Generic | 6.76% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 28.06% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
Alembic Pharmaceuticals Limited
NSE:APLLTD |
Drug Manufacturers - Specialty & Generic | 0.14% |
Annual Asset Resilience Ratio for Shan Dong Dong-E E-Jiao Co Ltd (1998–2024)
The table below shows the annual Asset Resilience Ratio data for Shan Dong Dong-E E-Jiao Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 26.89% | CN¥3.52 Billion ≈ $514.97 Million |
CN¥13.09 Billion ≈ $1.92 Billion |
+8.02pp |
| 2023-12-31 | 18.87% | CN¥2.51 Billion ≈ $367.48 Million |
CN¥13.31 Billion ≈ $1.95 Billion |
+4.14pp |
| 2022-12-31 | 14.73% | CN¥1.86 Billion ≈ $272.29 Million |
CN¥12.63 Billion ≈ $1.85 Billion |
-6.48pp |
| 2021-12-31 | 21.21% | CN¥2.47 Billion ≈ $360.97 Million |
CN¥11.63 Billion ≈ $1.70 Billion |
+8.10pp |
| 2020-12-31 | 13.11% | CN¥1.44 Billion ≈ $210.11 Million |
CN¥10.95 Billion ≈ $1.60 Billion |
+7.67pp |
| 2019-12-31 | 5.44% | CN¥633.79 Million ≈ $92.74 Million |
CN¥11.65 Billion ≈ $1.71 Billion |
-14.07pp |
| 2018-12-31 | 19.51% | CN¥2.71 Billion ≈ $395.95 Million |
CN¥13.87 Billion ≈ $2.03 Billion |
-4.25pp |
| 2017-12-31 | 23.76% | CN¥2.94 Billion ≈ $430.25 Million |
CN¥12.38 Billion ≈ $1.81 Billion |
+0.70pp |
| 2016-12-31 | 23.05% | CN¥2.29 Billion ≈ $335.64 Million |
CN¥9.95 Billion ≈ $1.46 Billion |
-1.67pp |
| 2015-12-31 | 24.72% | CN¥2.13 Billion ≈ $311.40 Million |
CN¥8.61 Billion ≈ $1.26 Billion |
+13.33pp |
| 2014-12-31 | 11.39% | CN¥849.80 Million ≈ $124.35 Million |
CN¥7.46 Billion ≈ $1.09 Billion |
+9.15pp |
| 2000-12-31 | 2.24% | CN¥19.55 Million ≈ $2.86 Million |
CN¥871.02 Million ≈ $127.46 Million |
+0.08pp |
| 1998-12-31 | 2.16% | CN¥10.00 Million ≈ $1.46 Million |
CN¥462.74 Million ≈ $67.71 Million |
-- |
About Shan Dong Dong-E E-Jiao Co Ltd
Dong-E-E-Jiao Co.,Ltd. engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China. Its products include Ejiao, a Chinese tonic herbal medicine; compound donkey-hide gelatin paste; a donkey-hide gelatin cake under Peach Blossom Princess name; instant donkey-hide gelatin powder; donkey-hide gelatin, meat, and pineapple puree under t… Read more